Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No significant changes to the study record are evident; the page content and major sections appear unchanged.
    Difference
    0.5%
    Check dated 2025-10-27T21:09:05.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 and added a government-operating-status notice with links; removed the previous v3.1.0 reference.
    Difference
    5%
    Check dated 2025-10-06T08:23:32.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Term naming updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a version bump to v3.1.0.
    Difference
    0.4%
    Check dated 2025-09-29T04:55:26.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated to v3.0.2; old tag v3.0.1 and the Back to Top element were removed. No substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.3%
    Check dated 2025-09-14T23:12:11.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-07T19:54:00.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed related to clear cell renal carcinoma and sitravatinib. Notably, several terms related to antineoplastic agents and immune checkpoint inhibitors have been removed.
    Difference
    13%
    Check dated 2025-08-31T12:37:40.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.